E Mingyan

565 total citations · 1 hit paper
31 papers, 420 citations indexed

About

E Mingyan is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E Mingyan has authored 31 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E Mingyan's work include Lung Cancer Treatments and Mutations (4 papers), Circular RNAs in diseases (4 papers) and Esophageal Cancer Research and Treatment (3 papers). E Mingyan is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Circular RNAs in diseases (4 papers) and Esophageal Cancer Research and Treatment (3 papers). E Mingyan collaborates with scholars based in China, United States and Poland. E Mingyan's co-authors include Anxin Gu, Guohui Liu, Yunlong He, Bo Yu, Shuang Liu, Chunbo Wang, Qiang Yao, Yuqi Zhang, Yongwu Li and Guanghua Rong and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

E Mingyan

24 papers receiving 415 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis

2024 54 citations Zhonghua Tong, Naixin Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Mingyan China	11	211	162	106	73	60	31	420
Xuyu Gu China	11	225 1.1×	158 1.0×	117 1.1×	79 1.1×	34 0.6×	37	444
Zongjuan Ming China	13	275 1.3×	141 0.9×	103 1.0×	130 1.8×	30 0.5×	32	480
Tasnuva D. Kabir Australia	9	291 1.4×	232 1.4×	75 0.7×	117 1.6×	26 0.4×	12	546
Hao Qin China	11	224 1.1×	198 1.2×	47 0.4×	70 1.0×	30 0.5×	28	466
Yue‐Can Zeng China	14	192 0.9×	78 0.5×	182 1.7×	62 0.8×	39 0.7×	29	460
Weimin Ren China	15	317 1.5×	244 1.5×	105 1.0×	75 1.0×	25 0.4×	23	543
Annabella Di Mauro Italy	12	158 0.7×	90 0.6×	155 1.5×	46 0.6×	42 0.7×	41	401
Sonia Patel United States	8	187 0.9×	84 0.5×	204 1.9×	105 1.4×	42 0.7×	13	506
Mutsushi Yamasaki Japan	11	190 0.9×	106 0.7×	89 0.8×	97 1.3×	35 0.6×	29	414
Guinv Hu China	12	237 1.1×	151 0.9×	104 1.0×	48 0.7×	15 0.3×	24	383

Countries citing papers authored by E Mingyan

Since Specialization

Citations

This map shows the geographic impact of E Mingyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Mingyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Mingyan more than expected).

Fields of papers citing papers by E Mingyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Mingyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Mingyan. The network helps show where E Mingyan may publish in the future.

Co-authorship network of co-authors of E Mingyan

This figure shows the co-authorship network connecting the top 25 collaborators of E Mingyan. A scholar is included among the top collaborators of E Mingyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Mingyan. E Mingyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Yi‐Long, Lin Wu, Nan Bi, et al.. (2025). PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy. Journal of Hematology & Oncology. 18(1). 111–111.

Wang, Xiaoqi, Jing Sui, Jiawei Yang, et al.. (2025). Alpha-lipoic acid attenuates cardiac inflammation of CVB3 induced viral myocarditis via neutrophil-derived YM-1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1872(1). 168034–168034.

Mingyan, E, et al.. (2025). Enhancing Teamwork and Clinical Competence in Radiotherapy Education: Integrating TeamSTEPPS with PEARLS Structured Debriefing in Scenario-Based Simulations. Advances in Medical Education and Practice. Volume 16. 849–860.

Chen, Ming, E Mingyan, Li Zhang, et al.. (2025). Clinical features and outcomes of unresectable locally advanced lung adenocarcinoma with uncommon EGFR mutations: a retrospective multi-center Chinese study. Translational Lung Cancer Research. 14(1). 96–106.

Tang, Fan, Miao Yan, Yige Liu, et al.. (2025). Mitochondrial Metabolite Methylmalonic Acid, Subclinical Myocardial Injury, and its Incremental Predictive Value for Cardiovascular Mortality Risk. Archives of Medical Research. 56(6). 103226–103226. 1 indexed citations

He, Yunlong, et al.. (2024). The cellular signaling and regulatory role of protein phosphatase in tumor diagnosis: Upstream miRNAs of PTEN. International Journal of Biological Macromolecules. 280(Pt 4). 136179–136179.

Lin, Quan, et al.. (2024). Tricetin attenuates atherosclerosis by suppressing macrophage ferroptosis via activation of the NRF2 pathway. International Immunopharmacology. 143(Pt 2). 113418–113418. 3 indexed citations

Meng, Chi, Ying Li, Duo Wang, et al.. (2023). Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells’ resistance to anti-tumour drugs. Frontiers in Pharmacology. 14. 1189245–1189245. 4 indexed citations

Wang, Shanjie, Junchen Guo, Xiaoxuan Liu, et al.. (2023). Sexual dimorphism in mitochondrial dysfunction and diabetes mellitus: evidence from a population-based cohort study. Diabetology & Metabolic Syndrome. 15(1). 114–114. 9 indexed citations

10.

Zhuang, Ming, Shan Jiang, Anxin Gu, Xuesong Chen, & E Mingyan. (2021). Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer. Translational Oncology. 14(12). 101210–101210. 15 indexed citations

11.

Liu, Guijun, E Mingyan, Ying Li, et al.. (2021). Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma. European Journal of Pharmacology. 906. 174214–174214. 23 indexed citations

12.

Liu, Guijun, Lina Feng, Ying Li, et al.. (2021). PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies. Frontiers in Immunology. 12. 665970–665970. 43 indexed citations

13.

Chen, Qi, Ge Mang, Jian Wu, et al.. (2020). Circular RNA circSnx5 Controls Immunogenicity of Dendritic Cells through the miR-544/SOCS1 Axis and PU.1 Activity Regulation. Molecular Therapy. 28(11). 2503–2518. 44 indexed citations

14.

Liu, Guohui, Chunbo Wang, Yunlong He, & E Mingyan. (2019). Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours. BMC Pharmacology and Toxicology. 20(1). 61–61. 8 indexed citations

15.

He, Yunlong, et al.. (2018). CircVRK1 regulates tumor progression and radioresistance in esophageal squamous cell carcinoma by regulating miR-624-3p/PTEN/PI3K/AKT signaling pathway. International Journal of Biological Macromolecules. 125. 116–123. 66 indexed citations

16.

Gu, Anxin, et al.. (2016). Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer. Reproductive Sciences. 24(2). 291–299. 39 indexed citations

17.

Gu, Anxin, et al.. (2015). RhNRG-1β Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway. PLoS ONE. 10(9). e0137337–e0137337. 22 indexed citations

18.

Mingyan, E, Hongli Li, Shufeng Li, & Bo Yu. (2008). Effects of Pyrrolidine Dithiocarbamate on Antioxidant Enzymes in Cardiomyopathy Induced by Adriamycin in Rats. Cardiology. 111(2). 119–125. 12 indexed citations

19.

Mingyan, E, et al.. (2007). Adriamycin induces myocardium apoptosis through activation of nuclear factor κB in rat. Molecular Biology Reports. 35(4). 489–494. 23 indexed citations

20.

Mingyan, E, et al.. (2003). The effects of ethanol extract of Caesalpinia sappan L on serum Th1 cytokine levels after rat heterotopic heart transplantation. 31(3). 212–215. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact